Yi‐Jun Wang
Harvard University(US)Xuzhou Medical College(CN)California Institute for Regenerative Medicine(US)Peking University(CN)Institute for Stem Cell Biology and Regenerative Medicine(IN)National Clinical Research Center for Digestive Diseases(CN)Beijing National Laboratory for Molecular Sciences(CN)Henan Provincial People's Hospital(CN)Institute of Chemistry(CN)University of Chinese Academy of Sciences(CN)University of California, Berkeley(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Cancer therapeutics and mechanisms, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Immunogenic effects of chemotherapy-induced tumor cell death(2018)295 cited
- → IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients(2013)224 cited
- → The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation.(1995)188 cited
- → Multidrug Resistance Proteins (MRPs) and Cancer Therapy(2015)182 cited
- → Costimulation Through the CD137/4-1BB Pathway Protects Human Melanoma Tumor-infiltrating Lymphocytes From Activation-induced Cell Death and Enhances Antitumor Effector Function(2011)135 cited
- → Melanoma Cells Express ICOS Ligand to Promote the Activation and Expansion of T-Regulatory Cells(2010)134 cited